SpringWorks Therapeutics Overview

SpringWorks Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for SWTX.

Quarterly EBIT

-$80.54M

↑ 14.26% YoY

As of Mar 31, 2025

Annual EBIT (TTM)

-$264.74M

↑ 26.39% YoY

Trailing 12 months ending Mar 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin